Deltatsine is primarily used in research settings for its potential neuroprotective properties. It has shown activity in modulating neuronal ion channels, which may contribute to its observed effects in reducing neuronal excitotoxicity. This makes it a compound of interest in the study of neurodegenerative conditions such as Alzheimer's and Parkinson’s diseases.

It is also investigated for its anti-inflammatory effects in central nervous system tissues, suggesting possible applications in managing neuroinflammation. Due to its ability to cross the blood-brain barrier efficiently, Deltatsine serves as a valuable tool in preclinical studies aiming to develop new central nervous system-active therapeutics.

Additionally, it has been explored for its analgesic potential, particularly in models of chronic pain, where it appears to interfere with pain signal transmission without significant sedative side effects. Its selectivity and potency make it suitable for use in pharmacological probes and target validation studies.